SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Rule 8.1- (Xploite plc) - Replacement

12 Apr 2010 17:06

RNS Number : 0621K
Xploite PLC
12 April 2010
 



RULE 8 AMENDMENT

 

The 'Rule 8.1 - Xploite plc' announcement released on 12/04/2010 at 13.36 under RNS No 0390K has been amended.

 

Amendments are identified with an asterisk (*).

 

The full amended text is shown below.

 

 

FORM 8.1

 

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)

 

 

1...KEY INFORMATION

 

Name of person dealing (Note 1)

Ian Smith (Chief Executive)

Company dealt in

Xploite plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

10p Ordinary

Date of dealing

09/04/10

 

 

2...INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

4,070,575

18.7%

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell*

-

-

-

-

Total

4,070,575

18.7%

-

-

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

-

-

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell

-

-

-

-

Total

-

-

-

-

 

(c)..Rights to subscribe (Note 3)*

 

Class of relevant security:

Details

Ordinary Shares of 10p each

Call Option ('A' Options), which shall expire on 19 March 2017, are held in respect of 344,828 ordinary shares at an exercise price of 29p upon satisfaction of a share price performance condition of 58p.

 

3...DEALINGS (Note 4)

 

(a)..Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

Purchase

220,513

36p

 

 

(b)..Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

n/a

 

 

(c)..Options transactions in respect of existing securities

(i)..Writing, selling, purchasing or varying

 

Product

name,e.g.

call option

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option relates

(Note 7)

Exercise

price

Type, e.g.

American,

European

etc.

Expiry

date

Option money

paid/received

per unit (Note 5)

 

n/a

 

(ii)..Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

n/a

 

(d)..Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

n/a

 

4...OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Further details of the rights to subscribe referred to above are available in the Scheme Document which is available in the investor relations section of the company's website: http://www.xploite.co.uk/investors/recommended-proposal.php

 

Is a Supplemental Form 8 attached? (Note 9)........ NO

 

Date of disclosure

12 April 2010

Contact name

Ian Smith

Telephone number

+44 (0) 870 737 2001

Name of offeree/offeror with which associated

Xploite plc

Specify category and nature of associate status (Note 10)

Director of Xploite plc

 

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCGGUQCCUPUGAP
Date   Source Headline
1st Mar 20217:00 amRNSTrading Update
26th Feb 20215:04 pmRNSHolding(s) in Company
18th Feb 20217:00 amRNSContract win
8th Feb 20217:00 amRNSContract Win
13th Jan 20217:00 amRNSContract Win
25th Nov 20202:06 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSChange of Auditor
10th Nov 20207:00 amRNSDirector Share Purchase
9th Nov 20207:00 amRNSEmployee Share Awards and PDMR Dealings
14th Oct 20207:00 amRNSCFO Appointment
13th Oct 202010:42 amRNSHolding(s) in Company
13th Oct 202010:40 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
22nd Sep 20207:01 amRNSNotice of Results
22nd Sep 20207:00 amRNSAppointment of Nomad and Broker
21st Sep 20205:15 pmRNSAIM Rule 17 Schedule Two (g) Update
8th Sep 20203:06 pmRNSHolding(s) in Company
1st Sep 20203:48 pmRNSHolding(s) in Company
1st Sep 202012:33 pmRNSHolding(s) in Company
7th Aug 20208:56 amRNSHolding(s) in Company
4th Aug 20201:06 pmRNSHolding(s) in Company
28th Jul 202012:16 pmRNSResult of AGM
28th Jul 20207:00 amRNSAGM Statement
27th Jul 20202:11 pmRNSAnnual General Meeting Update
15th Jul 20201:31 pmRNSDirector Share Purchase
3rd Jul 20209:34 amRNSReport and Accounts and Notice of AGM
17th Jun 20207:00 amRNSDirectorate Change
12th Jun 20207:00 amRNSUS$2.6m Contract Win with the US State of Michigan
11th Jun 20207:00 amRNSFinal Results
29th May 20207:00 amRNSNotice of Results
20th May 20205:21 pmRNSHolding(s) in Company
1st Apr 20207:34 amRNSDirector/PDMR Shareholding
23rd Mar 20207:00 amRNSTrading Update
6th Mar 20207:00 amRNSProduct Innovation
13th Feb 20205:46 pmRNSHolding(s) in Company
10th Feb 20205:41 pmRNSHolding(s) in Company
8th Jan 20207:00 amRNSBusiness Update
6th Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSDirector Share Purchase
14th Oct 20197:00 amRNSInterim Results
8th Oct 20197:00 amRNS1Spatial London Pilot Win
13th Aug 201912:16 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 201910:31 amRNSHolding(s) in Company
30th Jul 20191:00 pmRNSResult of AGM
30th Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSReport and Accounts and Notice of AGM
28th Jun 20197:00 amRNSDirector Share Purchase
31st May 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.